AARD Company Profile and Key Details

NASDAQ : AARD

Aardvark Therapeutics Common Stock

$5.01

0.09+1.83%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Aardvark Therapeutics, Inc. Common Stock (AARD) stock surged +1.83%, trading at $5.01 on NASDAQ, up from the previous close of $4.92. The stock opened at $4.62, fluctuating between $4.54 and $5.01 in the recent session.

Stock Snapshot

4.92

Prev. Close

109.64M

Market Cap

4.54

Day Low

-1.56

P/E Ratio

-3.21

EPS (TTM)

N/A

Cash Flow per Share

4.62

Open

21.88M

Number of Shares

5.01

Day High

51.23%

Free Float in %

N/A

Book Value

209.38K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	4.87	5.01	4.54	5.01	209.38K
Sep 09, 2026	5.33	5.46	4.89	4.92	109.75K
Sep 08, 2026	5.33	5.71	5.10	5.33	164.75K
Sep 04, 2026	5.72	5.99	5.15	5.38	257.81K
Sep 03, 2026	5.92	6.19	5.60	5.73	89.32K
Sep 02, 2026	6.05	6.23	5.80	5.95	59.4K
Sep 01, 2026	6.00	6.25	5.81	5.92	85.01K
Aug 31, 2026	5.70	6.16	5.30	6.10	125.43K
Aug 28, 2026	6.47	6.47	5.62	5.79	142.72K
Aug 27, 2026	6.89	7.09	6.59	6.62	74.12K
Aug 26, 2026	7.29	7.30	6.21	6.81	111.93K
Aug 25, 2026	6.94	7.31	6.49	7.25	145.01K
Aug 24, 2026	6.75	6.97	6.28	6.88	83.3K
Aug 21, 2026	5.91	6.90	5.80	6.82	173.69K
Aug 20, 2026	6.76	7.12	5.76	5.89	250.19K
Aug 19, 2026	6.27	7.14	6.27	6.75	182.62K
Aug 18, 2026	6.78	6.86	6.05	6.15	79.11K
Aug 17, 2026	6.54	7.51	6.54	6.74	154.83K
Aug 14, 2026	6.46	6.82	6.18	6.54	69.14K
Aug 13, 2026	6.53	6.98	6.34	6.41	130.86K

Contact Details

San Diego, CA 92122

United States

https://aardvarktherapeutics.com 858 225 7696

About Company

Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's natural regulatory systems (innate homeostatic pathways) to combat metabolic disorders. The company's primary experimental drug, ARD-101, is an orally administered, gut-specific small molecule. It functions as an agonist, targeting particular bitter taste receptors found within the gut lumen. ARD-101 is currently undergoing a Phase III clinical trial for managing excessive hunger (hyperphagia) associated with Prader-Willi Syndrome. Additionally, it is in a Phase II trial for addressing hyperphagia linked to acquired hypothalamic obesity, often a result of craniopharyngioma treatments like surgery or radiation therapy. Aardvark Therapeutics is also advancing ARD-201, which is currently in Phase I clinical trials for the treatment of obesity. Established in 2017, the company is based in San Diego, California.

Stock Peers

ARGX

-18.27-1.82%

argenx SE$984.04 REGN

-14.39-1.78%

Regeneron Pharmaceuticals, Inc.$793.26 MDGL

-13.54-2.48%

Madrigal Pharmaceuticals, Inc.$533.12 VRTX

-6.56-1.26%

Vertex Pharmaceuticals Incorporated$514.56 UTHR

-2.96-0.58%

United Therapeutics Corporation$503.86 KRYS

-2.54-0.73%

Krystal Biotech, Inc.$345.55 ONC

-9.2-2.62%

BeOne Medicines AG$341.80 PRAX

-6.73-1.95%

Praxis Precision Medicines, Inc.$338.57 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

1.2+0.42%

Ligand Pharmaceuticals Incorporated$289.25

Frequently Asked Questions

What is the current Aardvark Therapeutics, Inc. Common Stock (AARD) stock price?

Aardvark Therapeutics, Inc. Common Stock (NASDAQ: AARD) stock price is $5.01 in the last trading session. During the trading session, AARD stock reached the peak price of $5.01 while $4.54 was the lowest point it dropped to. The percentage change in AARD stock occurred in the recent session was 1.83% while the dollar amount for the price change in AARD stock was $0.09.

AARD's industry and sector of operation?

The NASDAQ listed AARD is part of Biotechnology industry that operates in the broader Healthcare sector. Aardvark Therapeutics, Inc. Common Stock designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AARD?

No Data

How AARD did perform over past 52-week?

AARD's closing price is 49.55% higher than its 52-week low of $3.35 where as its distance from 52-week high of $17.94 is -72.07%.

How many employees does AARD have?

Number of AARD employees currently stands at 28.

Link for AARD official website?

Official Website of AARD is: https://aardvarktherapeutics.com

How do I contact AARD?

AARD could be contacted at phone 858 225 7696 and can also be accessed through its website. AARD operates from 4370 La Jolla Village Drive, San Diego, CA 92122, United States.

How many shares of AARD are traded daily?

AARD stock volume for the day was 209.38K shares. The average number of AARD shares traded daily for last 3 months was 252.82K.

What is the market cap of AARD currently?

The market value of AARD currently stands at $109.64M with its latest stock price at $5.01 and 21.88M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	28
Beta	3.74
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	28
Beta	3.74
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

AARD Company Profile and Key Details

Aardvark Therapeutics Common Stock

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Financial & Profitability Overview

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways